Downregulated long non-coding RNA LINC01093 in liver fibrosis promotes hepatocyte apoptosis via increasing ubiquitination of SIRT1

Abstract

The apoptosis of hepatocytes contributes to the activation of hepatic stellate cells (HSCs), thus promoting the accumulation of extracellular matrix proteins and aggravating liver fibrosis. Silent information regulator 1 (SIRT1) is an anti-fibrotic protein whose downregulation induces hepatocyte apoptosis. This study aims to identify whether SIRT1 is regulated by long non-coding RNA LINC01093 and explore its underlying mechanisms. Liver fibrosis was induced in mice using CCl4, and the differential expressions of several fibrosis-related long noncoding RNAs were detected in liver tissues. The effect of LINC01093 on cell apoptosis and viability of hepatocytes were investigated after LINC01093 overexpression or knockdown using flow cytometry and MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. The anti-fibrotic effect of LINC01093 overexpression was observed in vivo. LncRNA LINC01093 is downregulated in CCl4-induced liver tissues and TGF-β1-stimulated hepatocytes. Downregulated LINC01093 promoted cell apoptosis and inhibited cell viability of hepatocytes. The co-culture between LINC01093-knockdown hepatocytes and HSCs increased the expressions of pro-fibrotic proteins. Downregulated LINC01093 promoted hepatocyte apoptosis via promoting degradation and ubiquitination of SIRT1 under TGF-β1 stimulation. The injection of LINC01093-overexpressing vectors alleviated liver fibrosis in vivo. In liver fibrosis, the downregulated LINC01093 promoted hepatocyte apoptosis, which is mediated by increasing the degradation and ubiquitination of SIRT1.

Glycyrrhizic Acid Attenuates Pulmonary Fibrosis of Silicosis by Inhibiting the Interaction between HMGB1 and BRG1 through PI3K/Akt/mTOR Pathway

“…Direct stimulation of TGF-β1 can induce the EMT process in A549 cells and play a corresponding role in the progression of pulmonary fibrosis. Therefore, as stated in the previous study [ 16 , 23 ], we used the medium containing 5 ng/mL TGF-β1 to establish an in vitro EMT model. The results proved that the in vitro EMT model was successfully constructed, but the mechanism of EMT is not clear.…”

Role of Long Noncoding RNAs in the Regulation of Cellular Immune Response and Inflammatory Diseases

“…LncRNAs regulate inflammatory factor expression and inflammatory signaling pathways by interacting with specific miRNAs, mRNAs, and proteins at the transcriptional and post-transcriptional levels, ultimately alleviating inflammatory damage. At present, some progress has been made regarding research on lncRNAs in the diagnosis and treatment of inflammatory diseases such as acute kidney injury (AKI) [ 64 ], liver inflammation [ 65 ], ALI [ 66 ], OA [ 67 ], mastitis [ 68 ], and neuroinflammation [ 69 ] ( Table 2 ). This section primarily focuses on the roles of lncRNAs in inflammatory diseases, to provide some reference for further research on lncRNAs in inflammatory diseases.…”

The role of long non-coding RNAs in human carcinoma

“…LncRNA LINC01093 is downregulated in CCl4-induced mice liver fibrosis tissues and promoted hepatocyte apoptosis, which can be abolished by the over expressed LINC01093. 14 LncRNAs HOTTIP (HOXA transcript at the distal tip), which can regulate miR-455-3p via competing endogenous RNA (ceRNA), play pivotal roles in osteoarthritis (OA) by negatively regulated miR-455-3p and increased the chemokine CCL3 levels in human primary chondrocyte. 15,16 Some LncRNAs are the potential regulators of proliferative retinopathy, and some LncRNAs may be involved in modulating host immune response to TB infection.…”